96 related articles for article (PubMed ID: 10406648)
1. Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Zegrocka O; Henary M; Say M; Mokrosz MJ; Kotecka BM; Manzel L; Macfarlane DE
Bioorg Med Chem Lett; 1999 Jul; 9(13):1819-24. PubMed ID: 10406648
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Say M; Henary M; Ruiz P; Manzel L; Macfarlane DE; Bojarski AJ
J Med Chem; 2003 Mar; 46(7):1242-9. PubMed ID: 12646034
[TBL] [Abstract][Full Text] [Related]
3. Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Say M; Zegrocka O; Tanious FA; Wilson WD; Manzel L; Macfarlane DE
Bioorg Med Chem; 2003 Mar; 11(6):1079-85. PubMed ID: 12614895
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.
Manzel L; Strekowski L; Ismail FM; Smith JC; Macfarlane DE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1337-47. PubMed ID: 10565859
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
6. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD
J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities.
Madrid PB; Sherrill J; Liou AP; Weisman JL; Derisi JL; Guy RK
Bioorg Med Chem Lett; 2005 Feb; 15(4):1015-8. PubMed ID: 15686903
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.
Morales-Ramos AI; Mecom JS; Kiesow TJ; Graybill TL; Brown GD; Aiyar NV; Davenport EA; Kallal LA; Knapp-Reed BA; Li P; Londregan AT; Morrow DM; Senadhi S; Thalji RK; Zhao S; Burns-Kurtis CL; Marino JP
Bioorg Med Chem Lett; 2008 Dec; 18(23):6222-6. PubMed ID: 18926700
[TBL] [Abstract][Full Text] [Related]
9. N-[omega-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands.
Lacivita E; Leopoldo M
J Med Chem; 2008 Mar; 51(5):1492-5. PubMed ID: 18269229
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates.
Jain M; Vangapandu S; Sachdeva S; Jain R
Bioorg Med Chem; 2004 Mar; 12(5):1003-10. PubMed ID: 14980613
[TBL] [Abstract][Full Text] [Related]
11. Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases.
Yu D; Kandimalla ER; Zhao Q; Cong Y; Agrawal S
Bioorg Med Chem Lett; 2001 Sep; 11(17):2263-7. PubMed ID: 11527711
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines.
De D; Krogstad FM; Byers LD; Krogstad DJ
J Med Chem; 1998 Dec; 41(25):4918-26. PubMed ID: 9836608
[TBL] [Abstract][Full Text] [Related]
13. Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Paliakov E; Henary M; Say M; Patterson SE; Parker A; Manzel L; Macfarlane DE; Bojarski AJ; Strekowski L
Bioorg Med Chem; 2007 Jan; 15(1):324-32. PubMed ID: 17049254
[TBL] [Abstract][Full Text] [Related]
14. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.
Bernard MP; Phipps RP
Clin Immunol; 2007 Nov; 125(2):138-48. PubMed ID: 17728187
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
Chaung HC
Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
[TBL] [Abstract][Full Text] [Related]
17. [Antimalarial active 10 H-indolo(3,2-b)quinolin-11-yl-amine. 2. Chloroquine analogs].
Görlitzer K; Stockmann R; Walter RD
Pharmazie; 1995 Feb; 50(2):105-11. PubMed ID: 7700962
[TBL] [Abstract][Full Text] [Related]
18. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
Zhu FG; Marshall JS
J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
[TBL] [Abstract][Full Text] [Related]
19. [Thieno[3,4-c]quinoline-4-yl-amines--synthesis and investigation of activity against malaria].
Görlitzer K; Gabriel B; Jomaa H; Wiesner J
Pharmazie; 2006 Nov; 61(11):901-7. PubMed ID: 17152980
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotides.
Klinman DM; Currie D
Clin Exp Immunol; 2003 Aug; 133(2):227-32. PubMed ID: 12869028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
